Cite This        Tampung        Export Record
Judul Metabolism and Metabolomics of Liver in Health and Disease / edited by : Wahli, Walter ; Guillou, Hervé
Pengarang Walter, Wahli
Hervé, Guillou
EDISI -
Penerbitan MDPI - Multidisciplinary Digital Publishing Institute, 2021
Deskripsi Fisik 268 p. :Ilus.
ISBN 9783039436354, 9783039436361
Subjek MEDICINE AND NURSING
Catatan Women and men have probably never been concerned as much by their health as during this COVID-19 pandemic. In this context, lifestyle habits continue to be promoted as allies for daily prevention against diseases. This is valid also for metabolic diseases, among which many affect the liver and are risk factors for aggravating the disease course of COVID-19. In fact, liver diseases are currently a major global health problem. There is a huge range of liver diseases and non-alcoholic fatty liver disease (NAFLD) is the most common chronic hepatic condition, which in some patients progresses to cirrhosis and liver cancer. Currently, substantial efforts are being made to better understand NAFLD, especially, because there is no U.S. Food and Drug Administration (FDA)-approved pharmacological therapy. To explore this disease, metabolomics is the most recently developed omics technology after genomics, transcriptomics, and proteomics. Metabolomics is the large-scale analysis of molecules, known as metabolites that ar
Bentuk Karya Tidak ada kode yang sesuai
Target Pembaca Tidak ada kode yang sesuai
Lokasi Akses Online https://directory.doabooks.org/handle/20.500.12854/68388
https://oer.unair.ac.id/files/original/7c7c1c0eaf8f8ab59215f0394264bc5d.pdf

 
No Barcode No. Panggil Akses Lokasi Ketersediaan
076325192 616.39 Met Baca di tempat Perpustakaan Pusat - Online Resources
Ebook
Tersedia
Tag Ind1 Ind2 Isi
001 INLIS000000000159523
005 20250320103341
007 ta
008 250320################|##########|#|##
020 # # $a 9783039436354, 9783039436361
035 # # $a 0010-0325001142
082 # # $a 616.39
084 # # $a 616.39 Met
245 # # $a Metabolism and Metabolomics of Liver in Health and Disease /$c edited by : Wahli, Walter ; Guillou, Hervé
250 # # $a -
260 # # :$b MDPI - Multidisciplinary Digital Publishing Institute,$c 2021
300 # # $a 268 p. : $b Ilus.
505 # # $a Women and men have probably never been concerned as much by their health as during this COVID-19 pandemic. In this context, lifestyle habits continue to be promoted as allies for daily prevention against diseases. This is valid also for metabolic diseases, among which many affect the liver and are risk factors for aggravating the disease course of COVID-19. In fact, liver diseases are currently a major global health problem. There is a huge range of liver diseases and non-alcoholic fatty liver disease (NAFLD) is the most common chronic hepatic condition, which in some patients progresses to cirrhosis and liver cancer. Currently, substantial efforts are being made to better understand NAFLD, especially, because there is no U.S. Food and Drug Administration (FDA)-approved pharmacological therapy. To explore this disease, metabolomics is the most recently developed omics technology after genomics, transcriptomics, and proteomics. Metabolomics is the large-scale analysis of molecules, known as metabolites that are intermediate or end products of metabolism found within cells, tissues, and biofluids. This technology has a very high potential to identify biomarker candidates for the future development of new therapeutics. The book features articles that address metabolomics technology and its use to document different liver functions and dysfunctions, with a major focus on NAFLD.
650 # # $a MEDICINE AND NURSING
700 1 # $a Hervé, Guillou
700 1 # $a Walter, Wahli
856 # # $a https://directory.doabooks.org/handle/20.500.12854/68388
856 # # $a https://oer.unair.ac.id/files/original/7c7c1c0eaf8f8ab59215f0394264bc5d.pdf
990 # # $a 076325192
Content Unduh katalog